drugset / Trial / NCT06552182
Phase 1 Study in Diabetes Mellitus(Fasting)
RandomizedCrossoverOpen-labelTreatment
Summary
An open-label, randomized, fasting, single-dose, 2-sequence, 2-period, crossover phase 1 study in healthy volunteers.
Timeline
- Start
- 2024-01-17
- Primary completion
- 2024-02-15
- Completion
- 2024-03-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HUC2-344 | Unknown | — | Oral |
| Subject | HUC2-344-R1 | Unknown | — | Oral |
| Subject | HUC2-344-R2 | Unknown | — | Oral |